AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12625640 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular EMG-controlled NMES
Number of subjects: 0
Study 12625640 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroprostheses systems
Number of subjects: 0
Study 12625640 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES technology
Number of subjects: 0
Study 10648330 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg ketamine
Number of subjects: 6
Study 10648330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 8887920 — intervention group
Group type: COMPARATOR
Intervention: argon laser treatment (ALT)
Number of subjects: 42
Study 8887920 — intervention group
Group type: EXPERIMENTAL
Intervention: double-frequency Nd:YAG laser treatment (NdLT)
Number of subjects: 42
Study 1726998 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 3400
Study 1726998 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3400
Study 6307964 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg oral dose of sultamicillin
Number of subjects: 6
Study 6307964 — intervention group
Group type: COMPARATOR
Intervention: IV dose of 441 mg ampicillin and 294 mg sulbactam
Number of subjects: 6
Study 3517643 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillamine (10 mg/kg/day)
Number of subjects: 162
Study 3517643 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (6 mg/kg/day)
Number of subjects: 162
Study 3517643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 30064404 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity Programme (SP) in Mental Health (1 h)
Number of subjects: 408
Study 30064404 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Health Literacy (MHL) Programme (6 h)
Number of subjects: 408
Study 30064404 — intervention group
Group type: EXPERIMENTAL
Intervention: MHL plus first-person Stigma Reduction (MHL + SR) (7 h)
Number of subjects: 408
Study 30064404 — intervention group
Group type: COMPARATOR
Intervention: Control group: waiting list
Number of subjects: 408
Study 27358263 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased serum folate levels
Number of subjects: 200
Study 27358263 — intervention group
Group type: COMPARATOR
Intervention: Healthy participants without CRA
Number of subjects: 200
Study 25440796 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab (75-150 mg biweekly injections)
Number of subjects: 18000
Study 25440796 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching injections)
Number of subjects: 18000
Study 22753208 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive agents for approximately 12 months
Number of subjects: 108
Study 19697090 — intervention group
Group type: EXPERIMENTAL
Intervention: Resurfacing arthroplasty
Number of subjects: 107
Study 19697090 — intervention group
Group type: COMPARATOR
Intervention: Large-head metal-on-metal total hip arthroplasty
Number of subjects: 107
Study 18310581 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy plus treatment as usual
Number of subjects: 90
Study 18310581 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual only
Number of subjects: 90
Study 15964445 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Emergency Team (MET) system
Number of subjects: 23
Study 12678365 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal femoral derotation osteotomy
Number of subjects: 28
Study 12678365 — intervention group
Group type: COMPARATOR
Intervention: Proximal femoral derotation osteotomy
Number of subjects: 28
Study 11168249 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillary long-bar implant overdentures with palatal coverage
Number of subjects: 13
Study 11168249 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillary long-bar implant overdentures without palatal coverage
Number of subjects: 13
Study 11168249 — intervention group
Group type: COMPARATOR
Intervention: New conventional maxillary prostheses
Number of subjects: 13
Study 9027956 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioartificial liver (BAL) based on pig hepatocytes attached to microcarriers
Number of subjects: 0
Study 9027956 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal liver assist device (ELAD) containing a human liver‐derived tumor cell line
Number of subjects: 0
Study 1283586 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonists
Number of subjects: 0
Study 1283586 — intervention group
Group type: COMPARATOR
Intervention: Salt-restricted diet
Number of subjects: 0
Study 6133987 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted sodium diet
Number of subjects: 28
Study 6133987 — intervention group
Group type: COMPARATOR
Intervention: General health package (control)
Number of subjects: 28
Study 31888944 — intervention group
Group type: EXPERIMENTAL
Intervention: Free and easily accessible medicines (intervention)
Number of subjects: 524
Study 31888944 — intervention group
Group type: COMPARATOR
Intervention: Poor access (control)
Number of subjects: 524
Study 30262460 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted genetic risk score (GRS) derived from 204 variants representative of 160 CAD loci
Number of subjects: 7261
Study 30262460 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding the GRS to clinical predictors
Number of subjects: 7261
Study 26254237 — intervention group
Group type: EXPERIMENTAL
Intervention: GP care with additional exercise therapy (maximum of 12 sessions in the first 3 months and three booster sessions thereafter)
Number of subjects: 203
Study 26254237 — intervention group
Group type: COMPARATOR
Intervention: GP care only
Number of subjects: 203
Study 24870115 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive mechanical ventilation support for at least 3 h (3‐6 h) every night
Number of subjects: 80
Study 24870115 — intervention group
Group type: COMPARATOR
Intervention: Standard medications
Number of subjects: 80
Study 22730862 — intervention group
Group type: EXPERIMENTAL
Intervention: Timely bolus insulin (0.2 iu/kg at aortic cannulation, additional 0.1 iu/kg for BG > 10.0 mmol/L)
Number of subjects: 422
Study 22730862 — intervention group
Group type: COMPARATOR
Intervention: Conventional glucose management (historical case-matched controls)
Number of subjects: 422
Study 22730862 — intervention group
Group type: EXPERIMENTAL
Intervention: Timely bolus insulin
Number of subjects: 422
Study 22730862 — intervention group
Group type: COMPARATOR
Intervention: Conventional glucose management
Number of subjects: 422
Study 20592005 — intervention group
Group type: COMPARATOR
Intervention: Consistently housed group
Number of subjects: 622
Study 20592005 — intervention group
Group type: COMPARATOR
Intervention: Housed at baseline but homeless at final follow-up
Number of subjects: 622
Study 20592005 — intervention group
Group type: COMPARATOR
Intervention: All homeless groups
Number of subjects: 622
Study 20592005 — intervention group
Group type: COMPARATOR
Intervention: Consistently homeless group
Number of subjects: 622
Study 18315977 — intervention group
Group type: EXPERIMENTAL
Intervention: CNC group
Number of subjects: 16
Study 18315977 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study 16463836 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracranial venous drainage evaluation using MR Venography and flow measurements in IIH patients
Number of subjects: 8
Study 16463836 — intervention group
Group type: COMPARATOR
Intervention: Control group of healthy subjects, 8 subjects
Number of subjects: 8
Study 12185702 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternity School training program
Number of subjects: 87
Study 12185702 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 87
Study 11486156 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg three times a day)
Number of subjects: 18
Study 11486156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 9045106 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated Lactobacillus acidophilus LB with rehydratant treatment for acute enteritis
Number of subjects: 63
Study 9045106 — intervention group
Group type: COMPARATOR
Intervention: No bacteriotherapeutic drug (control group)
Number of subjects: 63
Study 9045106 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated Lactobacillus acidophilus with antibiotic therapy for extraintestinal pathologies
Number of subjects: 63
Study 2003833 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0
Study 2003833 — intervention group
Group type: COMPARATOR
Intervention: Radiosensitizers (hyperbaric oxygen, misonidazole)
Number of subjects: 0
Study 2003833 — intervention group
Group type: COMPARATOR
Intervention: Irradiation of the para-aortic nodes
Number of subjects: 0
Study 2003833 — intervention group
Group type: COMPARATOR
Intervention: Pre-emptive chemotherapy with cisplatin
Number of subjects: 0
Study 2003833 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective total cystectomy
Number of subjects: 0
Study 6733040 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-contact dithranol therapy
Number of subjects: 43
Study 6733040 — intervention group
Group type: COMPARATOR
Intervention: Ingram regime
Number of subjects: 43
Study 6733040 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimes
Number of subjects: 43
Study 30879707 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly low-grade (I-II) Kaltenborn manual mobilization of the hands
Number of subjects: 20
Study 30879707 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated hand)
Number of subjects: 20
Study 30006117 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-implant mandibular overdentures (SIMO)
Number of subjects: 84
Study 30006117 — intervention group
Group type: COMPARATOR
Intervention: Conventional complete dentures (CCD)
Number of subjects: 84
Study 26828801 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraspinous lidocaine injection, analgesics, and exercises (LID-INJ)
Number of subjects: 378
Study 26828801 — intervention group
Group type: COMPARATOR
Intervention: Sham paraspinous lidocaine injection, analgesics, and exercises (SH-INJ)
Number of subjects: 378
Study 26828801 — intervention group
Group type: COMPARATOR
Intervention: Analgesics and exercises (STD-TTR)
Number of subjects: 378
Study 24249680 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-initiated multidisciplinary strategy (education, pain medication management, physiotherapy-guided exercise, communication with primary care physician)
Number of subjects: 0
Study 24249680 — intervention group
Group type: COMPARATOR
Intervention: Usual care and a pamphlet
Number of subjects: 0
Study 23113511 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-thermal, non-ablative CO(2) laser therapy (NACLT)
Number of subjects: 10
Study 23113511 — intervention group
Group type: COMPARATOR
Intervention: Placebo (inactive probe)
Number of subjects: 10
Study 19879576 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed reduction and internal fixation with three cancellous screws
Number of subjects: 455
Study 19879576 — intervention group
Group type: COMPARATOR
Intervention: Uncemented hemiarthroplasty
Number of subjects: 455
Study 18040672 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil plus placebo
Number of subjects: 55
Study 18040672 — intervention group
Group type: COMPARATOR
Intervention: Bosentan plus placebo
Number of subjects: 55
Study 18040672 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil plus bosentan
Number of subjects: 55
Study 15712100 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin (750 mg iv q24h)
Number of subjects: 222
Study 15712100 — intervention group
Group type: COMPARATOR
Intervention: Imipenem-cilastatin (500-1000 mg iv q6-8h)
Number of subjects: 222
Study 15712100 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 222
Study 15712100 — intervention group
Group type: COMPARATOR
Intervention: Imipenem-cilastatin
Number of subjects: 222
Study 15712100 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin and Imipenem-cilastatin
Number of subjects: 222
Study 11902617 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who discovered disagreement with the Black person after 12 minutes of observation
Number of subjects: 0
Study 11902617 — intervention group
Group type: COMPARATOR
Intervention: Participants who discovered agreement with the Black person after 12 minutes of observation
Number of subjects: 0
Study 11902617 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who disagreed with the Black person
Number of subjects: 0
Study 9932953 — intervention group
Group type: COMPARATOR
Intervention: Male patients with PNH
Number of subjects: 17
Study 9932953 — intervention group
Group type: COMPARATOR
Intervention: Female patients with PNH
Number of subjects: 17
Study 9932953 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 17
Study 7598139 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-One diet plus continuous combined hormone-replacement therapy (conjugated estrogens 0.625 mg/d plus medroxyprogesterone 2.5 mg/d)
Number of subjects: 32
Study 7598139 — intervention group
Group type: COMPARATOR
Intervention: Step-One diet plus placebo
Number of subjects: 32
Study 2222986 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/day of baclofen
Number of subjects: 5
Study 2222986 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/day of baclofen
Number of subjects: 5
Study 2222986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 870547 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 16
Study 870547 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 16
Study 870547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31190490 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with venlafaxine hydrochloride (75 mg/day in 1st week, 150 mg/day in 2nd week, 225 mg/day from 3rd to 6th week)
Number of subjects: 60
Study 31190490 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine hydrochloride (75 mg/day in 1st week, 150 mg/day in 2nd week, 225 mg/day from 3rd to 6th week)
Number of subjects: 60
Study 31190490 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (normal group)
Number of subjects: 60
Study 28259608 — intervention group
Group type: EXPERIMENTAL
Intervention: Busulfan and melphalan
Number of subjects: 598
Study 28259608 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin, etoposide, and melphalan
Number of subjects: 598
Study 26553894 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including academic detailing, web-based treatment algorithms, and tailored patient information leaflets
Number of subjects: 196
Study 26553894 — intervention group
Group type: COMPARATOR
Intervention: Usual care with simple patient-level PIP feedback
Number of subjects: 196
Study 26553894 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 196
Study 26553894 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 196
Study 24009416 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic group (AG)
Number of subjects: 59
Study 24009416 — intervention group
Group type: EXPERIMENTAL
Intervention: Land group (LG)
Number of subjects: 59
Study 24009416 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 59
Study 21906314 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorella-derived multicomponent supplement (30 tablets per day for 4 weeks)
Number of subjects: 15
Study 21906314 — intervention group
Group type: COMPARATOR
Intervention: Placebo (30 tablets per day for 4 weeks)
Number of subjects: 15
Study 18495676 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning educational session
Number of subjects: 74
Study 18495676 — intervention group
Group type: COMPARATOR
Intervention: Lecture-based learning educational session
Number of subjects: 74
Study 16539560 — intervention group
Group type: EXPERIMENTAL
Intervention: Light curing the primer before contamination with blood or saliva
Number of subjects: 180
Study 16539560 — intervention group
Group type: COMPARATOR
Intervention: No light curing of the primer before contamination with blood or saliva
Number of subjects: 180
Study 12649401 — intervention group
Group type: EXPERIMENTAL
Intervention: Chimeric anti-TNFalpha antibodies (3 mg/kg, bimonthly i.v.)
Number of subjects: 15
Study 10976558 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil (5‐FU) plus mitomycin C (MMC)
Number of subjects: 8
Study 10976558 — intervention group
Group type: COMPARATOR
Intervention: 5‐fluorouracil (5‐FU) only
Number of subjects: 8
Study 9174227 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy combined with a healthy-eating lifestyle program
Number of subjects: 205
Study 9174227 — intervention group
Group type: COMPARATOR
Intervention: Control group (54 obese school children)
Number of subjects: 205
Study 8055999 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral captopril
Number of subjects: 874
Study 8055999 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral isosorbide mononitrate
Number of subjects: 874
Study 8055999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 874
Study 8055999 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium
Number of subjects: 874
Study 8055999 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 874
Study 2648642 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine treatment, 150 mg twice daily for four weeks
Number of subjects: 48
Study 4553942 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethacrynic acid
Number of subjects: 0
Study 4553942 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide
Number of subjects: 0
Study 4553942 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 0
Study 4553942 — intervention group
Group type: COMPARATOR
Intervention: Chlorthalidone
Number of subjects: 0
Study 4553942 — intervention group
Group type: COMPARATOR
Intervention: Physical exertion
Number of subjects: 0
Study 31885802 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 13
Study 31885802 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Exercise (CE)
Number of subjects: 13
Study 31885802 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 13
Study 28741425 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (600 mg)
Number of subjects: 73
Study 28741425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 25987833 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic clopidogrel bisulfate 75 mg film‐coated tablets
Number of subjects: 0
Study 25987833 — intervention group
Group type: COMPARATOR
Intervention: Plavix® clopidogrel bisulfate 75 mg film‐coated tablets
Number of subjects: 0
Study 23143849 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese males
Number of subjects: 306
Study 23143849 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese females
Number of subjects: 306
Study 23143849 — intervention group
Group type: COMPARATOR
Intervention: BMI >95th percentile (regardless of sex)
Number of subjects: 306
Study 23143849 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex interaction with obesity
Number of subjects: 306
Study 21459381 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional exercise treatment (twice a week for 3 months)
Number of subjects: 127
Study 19105212 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (HFL‐rTMS)
Number of subjects: 27
Study 19105212 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS (LFR‐rTMS)
Number of subjects: 27
Study 19105212 — intervention group
Group type: COMPARATOR
Intervention: Both HFL‐rTMS and LFR‐rTMS
Number of subjects: 27
Study 17598007 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH) - 5,000 IU iv bolus followed by 450 IU/kg/24 h for 72 hours (n = 7)
Number of subjects: 22
Study 17598007 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH; dalteparin) - 200 IU/kg sc once daily for 72 hours (n = 8)
Number of subjects: 22
Study 17598007 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH; dalteparin) - 100 IU/kg sc once (n = 8)
Number of subjects: 22
Study 17598007 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH) - 250 IU/kg sc once (n = 7)
Number of subjects: 22
Study 17598007 — intervention group
Group type: COMPARATOR
Intervention: Control - saline infusion for 12 hours (n = 7)
Number of subjects: 22
Study 15281515 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol 2 mg
Number of subjects: 150
Study 15281515 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% (40 mg)
Number of subjects: 150
Study 15281515 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 150
Study 11531036 — intervention group
Group type: EXPERIMENTAL
Intervention: Reparil‐Gel N (n = 32)
Number of subjects: 126
Study 11531036 — intervention group
Group type: EXPERIMENTAL
Intervention: Reparil‐Gel (n = 31)
Number of subjects: 126
Study 11531036 — intervention group
Group type: EXPERIMENTAL
Intervention: Reparil‐Sportgel (n = 32)
Number of subjects: 126
Study 11531036 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel (n = 31)
Number of subjects: 126
Study 8816121 — intervention group
Group type: EXPERIMENTAL
Intervention: Time Out! For Me (experimental group)
Number of subjects: 21
Study 8816121 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study 1460184 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (75 mg Zn/day)
Number of subjects: 33
Study 1460184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 1460184 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (75 mg Zn/day) in bulimics
Number of subjects: 33
Study 1460184 — intervention group
Group type: COMPARATOR
Intervention: Placebo in bulimics
Number of subjects: 33
Study 1460184 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (75 mg Zn/day) in anorexics
Number of subjects: 33
Study 1460184 — intervention group
Group type: COMPARATOR
Intervention: Placebo in anorexics
Number of subjects: 33
Study 2866965 — intervention group
Group type: EXPERIMENTAL
Intervention: bopindolol 1.35 mg/day
Number of subjects: 14